CARB-X
Accelerate a diverse portfolio of at least 20 high-quality antibacterial products towards clinical development leveraging $250 million in BARDA funds with matching funds from the Wellcome Trust and the AMR Centre.
CARB-X
Founded:
2016-07-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Wordpress Plugins Global Site Tag Nginx
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-04 | Clarametyx Biosciences | CARB-X investment in Grant - Clarametyx Biosciences | 3.89 M USD |
| 2021-08-05 | Vaxcyte | CARB-X investment in Grant - Vaxcyte | 3.2 M USD |
| 2021-06-08 | Accelerate Diagnostics | CARB-X investment in Grant - Accelerate Diagnostics | 578 K USD |
| 2021-06-01 | BioVersys | CARB-X investment in Grant - BioVersys | 4.35 M USD |
| 2021-05-27 | SNIPR Biome | CARB-X investment in Grant - SNIPR Biome | 10.2 M USD |
| 2021-05-19 | Basilea Pharmaceutica | CARB-X investment in Grant - Basilea Pharmaceutica | 2.7 M USD |
| 2021-05-18 | Summit Therapeutics | CARB-X investment in Grant - Summit Therapeutics | 4.1 M USD |
| 2021-05-10 | SpeeDx | CARB-X investment in Grant - SpeeDx | 1.8 M USD |
| 2021-04-27 | GenomeKey | CARB-X investment in Grant - GenomeKey | 9.5 M USD |
| 2021-04-20 | Baebies | CARB-X investment in Grant - Baebies | 11.6 M USD |